{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:19:55Z","timestamp":1787735995192,"version":"build-2784847793"},"reference-count":23,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CHARLES UNIVERSITY, Faculty of Medicine in Hradec Kralove, the Czech Republic, The Cooperation Program","award":["207043 SURG"],"award-info":[{"award-number":["207043 SURG"]}]},{"award":["207043 SURG"],"award-info":[{"award-number":["207043 SURG"]}],"id":[{"id":"https:\/\/ror.org\/024d6js02","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"MINISTRY OF EDUCATION, YOUTH AND SPORTS","doi-asserted-by":"publisher","award":["SVV-2025-260776"],"award-info":[{"award-number":["SVV-2025-260776"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"award":["SVV-2025-260776"],"award-info":[{"award-number":["SVV-2025-260776"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vision"],"abstract":"<jats:p>Neovascular age-related macular degeneration is a retinal disease of older adults causing central vision loss associated with macular neovascularization. Treatment response is commonly evaluated using visual acuity and retinal morphology. These measures may not fully reflect patient-perceived benefit. We report two older adults with neovascular age-related macular degeneration treated with faricimab who demonstrated discordance between clinical and patient-reported outcomes. In the first case, best-corrected visual acuity changed from 20\/200 to 20\/180 and central retinal thickness decreased from 480 to 389 \u00b5m, whereas the National Eye Institute Visual Function Questionnaire\u201325 score increased from 33.87 to 60.99 and the exploratory ordinal colour-vividness rating was 25 at baseline and 100 at follow-up. In the second case, best-corrected visual acuity improved from 20\/100 to 20\/45 and central retinal thickness decreased from 341 to 186 \u00b5m, whereas the National Eye Institute Visual Function Questionnaire\u201325 score declined from 67.08 to 33.17 and the exploratory ordinal colour-vividness rating was 75 at baseline and 25 at follow-up. Changes in patient-reported visual functioning may not always parallel conventional clinical outcomes, while the contrasting exploratory colour-vividness ratings observed in these two cases warrant further investigation.<\/jats:p>","DOI":"10.3390\/vision10040060","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:11:15Z","timestamp":1787731875000},"page":"60","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discordance Between Eye-Specific Clinical Outcomes and Patient-Reported Visual Function After Faricimab Treatment for Neovascular Age-Related Macular Degeneration: A Two-Case Report"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3976-844X","authenticated-orcid":false,"given":"Tereza","family":"Pa\u0159ilov\u00e1","sequence":"first","affiliation":[{"name":"Faculty of Medicine in Hradec Kr\u00e1lov\u00e9, Department of Preventive Medicine, Charles University, \u0160imkova 870, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libor","family":"Hejsek","sequence":"additional","affiliation":[{"name":"Eye Clinic, University Hospital Hradec Kr\u00e1lov\u00e9, Sokolsk\u00e1 581, 500 05 Hradec Kralove, Czech Republic"},{"name":"Faculty of Medicine in Hradec Kr\u00e1lov\u00e9, Eye Clinic, Charles University, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Hoda\u010dov\u00e1","sequence":"additional","affiliation":[{"name":"Faculty of Medicine in Hradec Kr\u00e1lov\u00e9, Department of Preventive Medicine, Charles University, \u0160imkova 870, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s41687-024-00775-z","article-title":"Health-related quality of life in patients with neovascular age-related macular degeneration: A prospective cohort study","volume":"8","author":"Kubin","year":"2024","journal-title":"J. Patient-Rep. Outcomes"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2222545","DOI":"10.1080\/07853890.2023.2222545","article-title":"Incidence and prevalence of neovascular age-related macular degeneration: 15-year epidemiological study in a population-based cohort in Finland","volume":"55","author":"Kubin","year":"2023","journal-title":"Ann. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1111\/aos.15201","article-title":"The management of neovascular age-related macular degeneration: A systematic literature review of patient-reported outcomes, patient mental health and caregiver burden","volume":"101","author":"Gale","year":"2023","journal-title":"Acta Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/IAE.0000000000004702","article-title":"Optical coherence tomography and optical coherence tomography angiography biomarkers for predicting response to anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration","volume":"46","author":"Ucak","year":"2026","journal-title":"Retina"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.survophthal.2024.04.001","article-title":"Retinal and choroidal changes after anti-VEGF therapy in neovascular-AMD patients: A systematic review and meta-analysis of SD-OCT studies","volume":"69","author":"Salehi","year":"2024","journal-title":"Surv. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/s41433-022-02360-4","article-title":"Optical coherence tomography imaging biomarkers associated with neovascular age-related macular degeneration: A systematic review","volume":"37","author":"Hanson","year":"2023","journal-title":"Eye"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12955-019-1203-0","article-title":"Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population","volume":"17","author":"Jelin","year":"2019","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100066","DOI":"10.1016\/j.ajoint.2024.100066","article-title":"Factors affecting quality of life in patients with neovascular age-related macular degeneration","volume":"1","author":"Thinggaard","year":"2024","journal-title":"AJO Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/aos.15783","article-title":"Treatment burden on patients receiving intravitreal anti-VEGF for wet age-related macular degeneration","volume":"102","author":"Vinge","year":"2024","journal-title":"Acta Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.oret.2023.08.013","article-title":"Monocular and binocular visual function assessments and activities of daily living performance in age-related macular degeneration","volume":"8","author":"Peterson","year":"2024","journal-title":"Ophthalmol. Retin."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Almui\u00f1a-Varela, P., Garc\u00eda-Quintanilla, L., Rodr\u00edguez-Cid, M.J., Gil-Mart\u00ednez, M., Abraldes, M.J., G\u00f3mez-Ulla, F., Estany-Gestal, A., Alc\u00e1ntara-Espinosa, J.M., Fern\u00e1ndez-Rodr\u00edguez, M., and Fern\u00e1ndez-Ferreiro, A. (2024). Relationships between patient-reported outcome measures and clinical measures in na\u00efve neovascular age-related macular degeneration patients treated with intravitreal ranibizumab. Pharmaceuticals, 17.","DOI":"10.3390\/ph17020157"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.20344\/amp.24246","article-title":"Cuidados de Sa\u00fade Baseados em Valor no Tratamento da Degeneresc\u00eancia Macular da Idade: Resultados Cl\u00ednicos e Reportados pelos Doentes de um Estudo Multic\u00eantrico Portugu\u00eas","volume":"39","author":"Rodrigues","year":"2026","journal-title":"Acta Medica Port."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Fonteh, C.N., Mathias, M.T., Mandava, N., Manoharan, N., Lynch, A.M., Navo, R., Patnaik, J.L., and The University of Colorado Retina Research Group (2022). Mental health and visual acuity in patients with age-related macular degeneration. BMC Ophthalmol., 22.","DOI":"10.1186\/s12886-022-02602-9"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-list-item National Eye Institute Visual Function Questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archopht.116.2.227","article-title":"Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: Results from focus groups with visually impaired persons","volume":"116","author":"Mangione","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00417-022-05803-6","article-title":"The intraocular implant and visual rehabilitation improve the quality of life of elderly patients with geographic atrophy secondary to age-related macular degeneration","volume":"261","author":"Nekolova","year":"2023","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ophtha.2020.01.056","article-title":"Using uniocular visual acuity substantially underestimates the impact of visual impairment on quality of life compared with binocular visual acuity","volume":"127","author":"Man","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e000353","DOI":"10.1136\/bmjophth-2019-000353","article-title":"Patient-reported outcome measures in the management of neovascular age-related macular degeneration: A 1-year prospective study","volume":"4","author":"Jelin","year":"2019","journal-title":"BMJ Open Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1038\/s41433-023-02407-0","article-title":"Risk factors for poorer quality of life in patients with neovascular age-related macular degeneration: A longitudinal clinic-based study","volume":"37","author":"Vu","year":"2023","journal-title":"Eye"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1167\/iovs.08-3225","article-title":"Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: Validation studies from two phase 3 clinical trials","volume":"50","author":"Kokame","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Decleva, D., Vidal, K.S., Kreuz, A.C., de Menezes, P.A.H.L., and Ventura, D.F. (2023). Alterations of color vision and pupillary light responses in age-related macular degeneration. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.933453"},{"key":"ref_22","first-page":"311","article-title":"Prospective evaluation of visual acuity assessment: A comparison of Snellen versus ETDRS charts in clinical practice (An AOS Thesis)","volume":"107","author":"Kaiser","year":"2009","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.11.5.10","article-title":"The NEI VFQ-25C: Calibrating items in the National Eye Institute Visual Function Questionnaire-25 to enable comparison of outcome measures","volume":"11","author":"Goldstein","year":"2022","journal-title":"Transl. Vis. Sci. Technol."}],"container-title":["Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2411-5150\/10\/4\/60\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:40:23Z","timestamp":1787733623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2411-5150\/10\/4\/60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["vision10040060"],"URL":"https:\/\/doi.org\/10.3390\/vision10040060","relation":{},"ISSN":["2411-5150"],"issn-type":[{"value":"2411-5150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}